ACHC Stock Recent News

NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its private offering (the “Offering”) of $550 million in aggregate principal amount of 7.375% senior notes due 2033 (the “Notes”), which represents an increase of $50 million in aggregate principal amount from its previous announcement. The Offering is expected to close on March 10, 2025. The closing of the Offering is subject to the satisfaction of customa.

NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of $500 million in aggregate principal amount of senior notes due 2033 (the “Notes”), subject to market conditions and other considerations. The Company intends to use the proceeds from the Offering to prepay a portion of the outstanding borrowings under its existing senior secured revolving line of credit. The Note.

ACHC, TDW and RMR have been added to the Zacks Rank #5 (Strong Sell) List on March 5, 2025.

PHILADELPHIA, March 03, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia”) on behalf of the company's long-term shareholders.

NEW YORK, NY / ACCESS Newswire / March 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q4 2024 Earnings Conference Call February 28, 2025 9:00 AM ET Company Participants Patrick Feeley - Senior Vice President of Investor Relations Christopher Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners Brian Tanquilut - Jefferies A.J. Rice - UBS Ben Hendrix - RBC Capital Markets John Ransom - Raymond James Matthew Gillmor - KeyBanc Capital Markets Scott Fidel - Stephens Andrew Mok - Barclays Operator Hello, and welcome to the Acadia Healthcare Fourth Quarter 2024 Earnings Conference Call.

ACHC expects revenues to be between $3.3 billion and $3.4 billion in 2025.

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.64 per share, missing the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.85 per share a year ago.